Common Contracts
3 similar Key Executive Severance Agreement contracts by Neorx Corp
NEORX CORPORATION KEY EXECUTIVE SEVERANCE AGREEMENTKey Executive Severance Agreement • February 23rd, 2004 • Neorx Corp • In vitro & in vivo diagnostic substances
This Key Executive Severance Agreement (VP) (this "Agreement"), dated as of February 28, 2003, is entered into by and between NEORX CORPORATION, a Washington corporation (as supplemented by Section 10, the "Company"), and Linda Findlay (the "Executive").
NEORX CORPORATION KEY EXECUTIVE SEVERANCE AGREEMENTKey Executive Severance Agreement • February 23rd, 2004 • Neorx Corp • In vitro & in vivo diagnostic substances
This Key Executive Severance Agreement (VP) (this "Agreement"), dated as of February 28, 2003, is entered into by and between NEORX CORPORATION, a Washington corporation (as supplemented by Section 10, the "Company"), and Anna Wight (the "Executive").
NEORX CORPORATION KEY EXECUTIVE SEVERANCE AGREEMENTKey Executive Severance Agreement • February 23rd, 2004 • Neorx Corp • In vitro & in vivo diagnostic substances
This Key Executive Severance Agreement (VP) (this "Agreement"), dated as of February 28, 2003, is entered into by and between NEORX CORPORATION, a Washington corporation (as supplemented by Section 10, the "Company"), and Melinda Kile (the "Executive").
